Literature DB >> 8587610

Insulin action impaired by deficiency of the G-protein subunit G ialpha2.

C M Moxham1, C C Malbon.   

Abstract

Integration of information between tyrosine kinase and G-protein-mediated pathways is necessary, but remains poorly understood. Here we use cells from transgenic mice harbouring inducible expression of RNA antisense to the gene encoding G ialpha2 to show that G ialpha2 is critical for insulin action. G ialpha2 deficiency in adipose tissue and liver produces hyperinsulinaemia, impaired glucose tolerance and resistance to insulin in vivo. Insulin resistance affects glucose-transporter activity and recruitment, counterregulation of lipolysis, and activation of glycogen synthase, all of which are cardinal responses to insulin. G ialpha2 deficiency increases protein-tyrosine phosphatase activity and attenuates insulin-stimulated tyrosine phosphorylation of IRS (insulin-receptor substrate 1) in vivo. G ialpha2 deficiency creates a model for insulin resistance characteristic of noninsulin-dependent diabetes mellitus (NIDDM), implicating G ialpha2 as a positive regulator of insulin action.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8587610     DOI: 10.1038/379840a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  51 in total

1.  Involvement of Gialpha2 in sodium butyrate-induced erythroblastic differentiation of K562 cells.

Authors:  M G Davis; Y Kawai; I J Arinze
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

Review 2.  Control of body weight: a physiologic and transgenic perspective.

Authors:  G Frühbeck; J Gómez-Ambrosi
Journal:  Diabetologia       Date:  2003-02-15       Impact factor: 10.122

Review 3.  Apelin and insulin resistance: another arrow for the quiver?

Authors:  Shiming Xu; Philip S Tsao; Patrick Yue
Journal:  J Diabetes       Date:  2011-09       Impact factor: 4.006

4.  GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulation.

Authors:  Isao Usui; Takeshi Imamura; Hiroaki Satoh; Jie Huang; Jennie L Babendure; Christopher J Hupfeld; Jerrold M Olefsky
Journal:  EMBO J       Date:  2004-07-08       Impact factor: 11.598

Review 5.  Heterotrimeric G proteins and the single-transmembrane domain IGF-II/M6P receptor: functional interaction and relevance to cell signaling.

Authors:  C Hawkes; A Amritraj; R G Macdonald; J H Jhamandas; S Kar
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

6.  Streptozotocin-induced diabetes impairs G-protein linked signal transduction in vascular smooth muscle.

Authors:  Shehla Hashim; Yi Yong Liu; Rui Wang; Madhu B Anand-Srivastava
Journal:  Mol Cell Biochem       Date:  2002-11       Impact factor: 3.396

7.  Bidirectional modulation of insulin action by amino acids.

Authors:  M E Patti; E Brambilla; L Luzi; E J Landaker; C R Kahn
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

8.  Agonist-specific alterations in receptor-phospholipase coupling following inactivation of Gi2alpha gene.

Authors:  R Mattera; S Hayek; B A Summers; D L Grove
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

Review 9.  Regulation of the insulin signalling pathway by cellular protein-tyrosine phosphatases.

Authors:  B J Goldstein; F Ahmad; W Ding; P M Li; W R Zhang
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

10.  Insulin induces heterologous desensitization of G-protein-coupled receptor and insulin-like growth factor I signaling by downregulating beta-arrestin-1.

Authors:  Stéphane Dalle; Takeshi Imamura; David W Rose; Dorothy Sears Worrall; Satoshi Ugi; Christopher J Hupfeld; Jerrold M Olefsky
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.